Regional Differences in Cerebral Noradrenaline Turnover in Mice Withdrawn from Repeated Morphine Treatment and Tolerance to the Effects of Acute Morphine
Authors:
- 1 September 1995
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 77 (3) , 196-203
Abstract
The effects of morphine withdrawal and challenge doses (10 or 30 mg/kg) on the α‐methyl‐p‐tyrosine (αMT)‐induced noradrenaline (NA) depletion as well as on the free 3‐methoxy‐4‐hydroxyphenylethylene glycol (MOPEG) concentration were studied in various brain areas of NMRI mice. Morphine was given subcutaneously 3 times daily for 5 days followed by 1 or 3 days'withdrawal. In morphine withdrawn mice the αMT‐induced NA depletion and the free MOPEG concentrations were differentially altered. At 1‐day withdrawal the αMT‐induced NA depletion was retarded and the NA concentration was elevated in the forebrain area indicating reduced release of NA. Simultaneously, however, the free MOPEG concentration was significantly elevated in the forebrain area and in the lower brain stem suggesting enhanced NA turnover. No withdrawal‐induced changes were found in the hypothalamic NA turnover. Acute morphine elevated the free MOPEG concentration and accelerated the αMT‐induced NA depletion in all brain areas of control mice but not in mice withdrawn for 1 day from repeated morphine treatment. At 3 days'withdrawal, however, the 30 mg/kg morphine dose slightly accelerated the NA depletion in the forebrain area. These results show that morphine withdrawal differentially alters the αMT‐induced NA depletion and the free MOPEG concentration in various mouse brain areas. These effects are relatively modest suggesting that in mice the noradrenergic mechanisms play a minor role in morphine withdrawal syndrome. However, in all brain areas of the morphine‐withdrawn mice tolerance was found towards the NA turnover and release accelerating effect of acute morphine.Keywords
This publication has 51 references indexed in Scilit:
- Morphine-6-glucoronide: A potent stimulator of locomotor activity in miceLife Sciences, 1994
- Cerebral dopamine and noradrenaline in mice withdrawn from repeated morphine treatment and development of tolerance to a test dose of morphineGeneral Pharmacology: The Vascular System, 1994
- Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in micePharmacology Biochemistry and Behavior, 1992
- Morphine-3-glucuronide - a potent antagonist of morphine analgesiaLife Sciences, 1990
- Differences in the Effects of Morphine on the α‐Methyl‐p‐tyrosine‐induced Depletion of Dopamine and Noradrenaline in Various Areas of the Mouse BrainBasic & Clinical Pharmacology & Toxicology, 1987
- The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administrationJournal of Neural Transmission, 1987
- Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: Biochemical and behavioral correlatesLife Sciences, 1984
- Neurochemical aspects of the opioid-induced ‘catatonia’Neurochemistry International, 1982
- Morphine and nigrostriatal function in the rat and mouse: The role of nigral and striatal opiate receptorsNeuropharmacology, 1982
- 14C-Catecholamine Synthesis in Mouse Brain during Morphine WithdrawalNature, 1972